Literature DB >> 4348278

Induction of arginase activity with the Shope papilloma virus in tissue culture cells from an argininemic patient.

S Rogers, A Lowenthal, H G Terheggen, J P Columbo.   

Abstract

Inoculation of the Shope virus in tissue cultures of human fibroblasts from a patient with a deficiency of the enzyme arginase results in an induction of arginase activity, apparently virus coded.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4348278      PMCID： PMC2139227          DOI： 10.1084/jem.137.4.1091

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  6 in total

1.  NEW PAPOVAVIRUS CONTAMINATING SHOPE PAPILLOMATA.

Authors:  J W HARTLEY; W P ROWE
Journal:  Science       Date:  1964-01-17       Impact factor: 47.728

2.  Measurement of cell growth in tissue culture with a phenol reagent (folin-ciocalteau).

Authors:  V I OYAMA; H EAGLE
Journal:  Proc Soc Exp Biol Med       Date:  1956-02

3.  L-asparaginase and blastogenesis.

Authors:  M S Weiner; W I Waithe; K Hirschhorn
Journal:  Lancet       Date:  1969-10-04       Impact factor: 79.321

4.  [Hyperargininemia wityh arginase deficiency. A new familial metabolic disease. I. Clinical studies].

Authors:  H G Terheggen; A Schwenk; A Lowenthal; M van Sande; J P Colombo
Journal:  Z Kinderheilkd       Date:  1970

5.  Change in the structure of Shope papilloma virus-induced arginase associated with mutation of the virus.

Authors:  S Rogers
Journal:  J Exp Med       Date:  1971-12-01       Impact factor: 14.307

6.  Studies of the mechanism of action of the Shope rabbit papilloma virus. I. Concerning the nature of the induction of arginase in the infected cells.

Authors:  S ROGERS; M MOORE
Journal:  J Exp Med       Date:  1963-03-01       Impact factor: 14.307
  6 in total
  18 in total

1.  Clinical application of somatic gene therapy in inborn errors of metabolism.

Authors:  F D Ledley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Unsuccessful trial of gene replacement in arginase deficiency.

Authors:  H G Terheggen; A Lowenthal; F Lavinha; J P Colombo; S Rogers
Journal:  Z Kinderheilkd       Date:  1975

Review 3.  Viral vectors: from virology to transgene expression.

Authors:  D Bouard; D Alazard-Dany; F-L Cosset
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

Review 4.  Translating gene transfer: a stalled effort.

Authors:  Alexandra J Greenberg; Jennifer McCormick; Carmen J Tapia; Anthony J Windebank
Journal:  Clin Transl Sci       Date:  2011-08       Impact factor: 4.689

5.  Human hyperargininemia: a mutation not expressed in skin fibroblasts?

Authors:  A F Van Elsen; J G Leroy
Journal:  Am J Hum Genet       Date:  1977-07       Impact factor: 11.025

6.  Arginase deficiency.

Authors:  R Christopher; V Rajivnath; K T Shetty
Journal:  Indian J Pediatr       Date:  1997 Mar-Apr       Impact factor: 1.967

7.  Genetic intervention: the modern chimera.

Authors:  D A Shephard
Journal:  Can Med Assoc J       Date:  1977-04-09       Impact factor: 8.262

8.  Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia.

Authors:  Young Mok Lee; Thomas J Conlon; Andrew Specht; Kirsten E Coleman; Laurie M Brown; Ana M Estrella; Monika Dambska; Kathryn R Dahlberg; David A Weinstein
Journal:  J Inherit Metab Dis       Date:  2018-05-25       Impact factor: 4.982

Review 9.  Gene therapy and gene correction: targets, progress, and challenges for treating human diseases.

Authors:  Matthew R Cring; Val C Sheffield
Journal:  Gene Ther       Date:  2020-10-09       Impact factor: 5.250

Review 10.  Gene Therapies for Cancer: Strategies, Challenges and Successes.

Authors:  Swadesh K Das; Mitchell E Menezes; Shilpa Bhatia; Xiang-Yang Wang; Luni Emdad; Devanand Sarkar; Paul B Fisher
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.